Medtrum Overview

  • Year Founded
  • 2008

Year Founded

  • Status
  • Private

  • Latest Deal Type
  • Series C

  • Latest Deal Amount
  • $29M

  • Investors
  • 8

Medtrum General Information

Description

Developer of diabetes management devices. The company develops and markets devices and related software used to manage and monitor glucose levels and insulin pump status of diabetic patients.

Contact Information

Website
www.medtrum.com
Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Corporate Office
  • Building 3, No. 200 Newton Road, Zhangjiang Hi-Tech Park
  • Shanghai
  • China
Primary Industry
Electronics (B2C)
Other Industries
Application Software
Vertical(s)
Digital Health, Wearables & Quantified Self, TMT, HealthTech, Mobile
Corporate Office
  • Building 3, No. 200 Newton Road, Zhangjiang Hi-Tech Park
  • Shanghai
  • China

Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Medtrum Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
3. Later Stage VC (Series C) 24-Dec-2018 $29M Completed Generating Revenue
2. Later Stage VC 16-Nov-2014 Completed Generating Revenue
1. Early Stage VC 31-Mar-2010 Completed Generating Revenue
To view Medtrum’s complete valuation and funding history, request access »

Medtrum Patents

Medtrum Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
US-D1019674-S1 Display screen or portion thereof with graphical user interface Active 29-Oct-2021
US-D1019675-S1 Display screen or portion thereof with graphical user interface Active 29-Oct-2021
EP-4424235-A1 Closed-loop artificial pancreatic insulin infusion control system Pending 25-Oct-2021
EP-4422496-A1 Closed-loop artificial pancreas insulin infusion control system Pending 25-Oct-2021
EP-4424234-A1 Closed-loop artificial pancreatic insulin infusion control system Pending 25-Oct-2021 A61B5/14532
To view Medtrum’s complete patent history, request access »

Medtrum Investors (8)

Investor Name Investor Type Holding Investor Since Participating Rounds
3E Bioventures (China) Venture Capital Minority
BOCGI Zheshang Capital Growth/Expansion Minority
Morningside Group Venture Capital Minority
Shanghai Nuokai Investment Management Venture Capital Minority
HongShan Venture Capital Minority
You’re viewing 5 of 8 investors. Get the full list »

Medtrum FAQs

  • When was Medtrum founded?

    Medtrum was founded in 2008.

  • Where is Medtrum headquartered?

    Medtrum is headquartered in Shanghai, China.

  • What industry is Medtrum in?

    Medtrum’s primary industry is Electronics (B2C).

  • Is Medtrum a private or public company?

    Medtrum is a Private company.

  • What is Medtrum’s current revenue?

    The current revenue for Medtrum is .

  • How much funding has Medtrum raised over time?

    Medtrum has raised $29M.

  • Who are Medtrum’s investors?

    3E Bioventures (China), BOCGI Zheshang Capital, Morningside Group, Shanghai Nuokai Investment Management, and HongShan are 5 of 8 investors who have invested in Medtrum.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read blog »
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process »